BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5997587)

  • 21. [Electron microscopic study of lung changes in white mice with experimental grippe].
    Kranchev AK
    Arkh Patol; 1966; 28(7):10-5. PubMed ID: 6001823
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect on influenza virus infection on the production of interferon by alveolar and peritoneal cells in vitro.
    Szulc B; Szalaty H
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):93-7. PubMed ID: 6158300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiviral effect of RNA in mice and in tissue culture].
    Sklianskaia EI; Peterson OP; Korabel'nikova NI; Balezina TI
    Antibiotiki; 1968 Feb; 13(2):171-6. PubMed ID: 4299199
    [No Abstract]   [Full Text] [Related]  

  • 24. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of interferon in experimental viral diseases].
    German A; Quero AM
    Bull Acad Natl Med; 1983 Feb; 167(2):163-9. PubMed ID: 6196097
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study on anti-influenza virus infection with yinqiao-decoction by orthogonal design].
    Wu ZQ; Liu GH; Yan LJ; Nan CH; Yue ZJ; Wang XF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):427-9. PubMed ID: 21604566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
    Hovden AO; Cox RJ; Madhun A; Haaheim LR
    Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection.
    Savov VM; Galabov AS; Tantcheva LP; Mileva MM; Pavlova EL; Stoeva ES; Braykova AA
    Exp Toxicol Pathol; 2006 Aug; 58(1):59-64. PubMed ID: 16793246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus.
    Mizuta T; Fujiwara M; Abe T; Miyano-Kurosaki N; Yokota T; Shigeta S; Takaku H
    Biochem Biophys Res Commun; 2000 Dec; 279(1):158-61. PubMed ID: 11112432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection.
    Gambaryan AS; Tuzikov AB; Chinarev AA; Juneja LR; Bovin NV; Matrosovich MN
    Antiviral Res; 2002 Jul; 55(1):201-5. PubMed ID: 12076764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nature of the "meta-influenza" stage of influenza].
    Tsingerling AV; Soldatova VM; Platonov VG
    Arkh Patol; 1980; 42(3):46-50. PubMed ID: 6769422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interferon formation in influenza].
    Zagorodnaia IS; Rybalko SL
    Vrach Delo; 1973 Jul; 7(7):135-7. PubMed ID: 4756035
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic effect of aminoadamantane aerosol in experimental influenza of albino mice].
    Solovev VN; Tolmacheva NS
    Farmakol Toksikol; 1968; 31(6):714-6. PubMed ID: 5713584
    [No Abstract]   [Full Text] [Related]  

  • 34. The relationship between interferon and virus virulence in influenza virus infections of the mouse.
    McLaren C; Potter CW
    J Med Microbiol; 1973 Feb; 6(1):21-32. PubMed ID: 4570477
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dependence of the cocarcinogenic action of the influenza virus on the nature of the influenza infection].
    Savtsova ZD; Grinevich IuA; Shevchenko IN; Nikol'skiĭ IS
    Biull Eksp Biol Med; 1984 Aug; 98(8):216-7. PubMed ID: 6466860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of some drugs and of ceruloplasmin on experimental influenza APR 8/34 (H0N1) infection in the mouse.
    Tomas E; Samuel I; Bârnaure F
    Virologie; 1979; 30(3):233-4. PubMed ID: 538885
    [No Abstract]   [Full Text] [Related]  

  • 37. [Interferon-inducing effect of influenza viruses following aerogenic and oral administration in NMRI mice].
    Schubert K; Bergmann KC; Noack K
    Z Erkr Atmungsorgane; 1983; 160(3):242-6. PubMed ID: 6192598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of Sendasi virus infection in mice. On the possible role of interferon on the development of disease.
    Degré M; Rollag H
    Acta Pathol Microbiol Scand B; 1980 Jun; 88(3):177-81. PubMed ID: 6160724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.
    Conti G; Magliani W; Conti S; Nencioni L; Sgarbanti R; Palamara AT; Polonelli L
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4331-7. PubMed ID: 18824612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the production of interferon in the process of adaptation of influenza type A2 virus to the mouse lung.
    Inglot AD; Lobodzińska M; Biernacka I; Niedźwiedzka E
    Arch Immunol Ther Exp (Warsz); 1966; 14(3):333-8. PubMed ID: 5919648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.